WCMNY
PEPLW

Westchester Capital Management (New York)’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Westchester Capital Management (New York)’s Portfolio PEPLW Stock Details PEPLW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,647
Closed -$326 – 411
2022
Q4 		$326 Buy
+29,647
New +$925 ﹤0.01% 437

Other funds holding PEPLW

BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Westchester Capital Management (New York)'s PEPLW Position: Q1 2023 in Review

Westchester Capital Management (New York) sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2023, closing a stake of 29,647 shares — an estimated $326 sold.

Westchester Capital Management (New York) first reported a position in PEPLW in Q4 2022 and held it in 1 quarter. The position peaked at $326 in Q4 2022. 23 funds tracked by Wall St. Rank hold PEPLW as of Q1 2023.

  • Westchester Capital Management (New York) reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2023 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 29,647 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2023, an estimated $326.
  • Westchester Capital Management (New York) first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2022 and held it in 1 quarter.
  • Westchester Capital Management (New York)'s PepperLime Health Acquisition Corporation Warrrant position peaked at $326 in Q4 2022.
  • 23 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2023, filed 15 May 2023.